Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
What’s Behind Cannabis Stock HERB? (click to learn more) Eshbal Acquires a 55% Interest in Dare to Be Different Foods (click to learn more) CSE: ALEN.U — AI Meets Digital Health (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Dynavax Technologies Corp DVAX

Healthcare Drug Manufacturers - Specialty & Generic
Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally. The company offers HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in adults aged 18 years and older; and CpG 1018, the adjuvant used in HEPLISAV-B. It also... see more

Recent & Breaking News (NDAQ:DVAX)

Halper Sadeh LLC Encourages DVAX, FONR, DBRG, ONTF Shareholders to Contact the Firm to Discuss Their Rights

GlobeNewswire January 6, 2026

$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger-DVAX, FONR, DBRG, and ONTF

GlobeNewswire January 6, 2026

Dynavax Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Dynavax Technologies Corporation - DVAX

Business Wire December 29, 2025

DVAX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Dynavax Technologies Corporation is Fair to Shareholders

Business Wire December 24, 2025

Dynavax to Participate at the 8th Annual Evercore Healthcare Conference

PR Newswire November 19, 2025

Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program

PR Newswire November 5, 2025

Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program

PR Newswire November 5, 2025

Dynavax to Report Third Quarter 2025 Financial Results and Host Conference Call on November 5, 2025

PR Newswire October 22, 2025

Dynavax Presents Positive Topline Data from Part 1 of Phase 1/2 Trial for Shingles Vaccine Candidate at IDWeek 2025 and Announces Initiation of Part 2 of Trial

PR Newswire October 21, 2025

Dynavax to Participate in the 2025 Wells Fargo Healthcare Conference

PR Newswire August 27, 2025

Dynavax Announces Positive Topline Phase 1/2 Results Supporting Potential Best-in-Class Shingles Vaccine Profile

PR Newswire August 21, 2025

Dynavax Reports Second Quarter 2025 Financial Results

PR Newswire August 7, 2025

Dynavax to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025

PR Newswire July 29, 2025

Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting

PR Newswire June 11, 2025

Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom

Business Wire June 9, 2025

Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting

PR Newswire June 9, 2025

Dynavax Comments on Glass Lewis Recommendation

PR Newswire June 4, 2025

Glass Lewis Recommends Shareholders Support Deep Track's Case for Board Change at Dynavax Technologies

Business Wire June 4, 2025

Dynavax to Present at William Blair's 45th Annual Growth Stock Conference

PR Newswire May 28, 2025

Deep Track Capital Comments on ISS Recommendation

Business Wire May 23, 2025

Podcasts